Work

Successful Rechallenge With Pembrolizumab After a Grade 3 Infusion Reaction With a Far Slower Infusion Rate and Premedication: A Case Report

Year: 2025
Type: article
Study design: Case Report
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4414947162
FWCI: 0.373
Cites: 11
Cited by: 1
Related to: